|
Eisai's New Drug Application for Insomnia Disorder Treatment Lemborexant in the USA
Eisai Co., Ltd. and Purdue Pharma announced that a new drug application has been submitted to the U.S. FDA for lemborexant, an investigational agent...
|
|
bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of Bio Pharma Technology in Asia
The bio-pharma industry has entered the new stage of rapid development in recent years with the continuous development of the cutting edge biological technology...
|
|